Skip to contentAnnouncements and coverage.
- · Business Wire
Talus Bio Launches Ptarmigan-1, the First Structure-Free AI Model for Proteome-Wide Drug Discovery (opens in a new tab)
Talus Bio announces the public launch of Ptarmigan-1 and access through ptarmigan.app.
- · bioRxiv
Structure-free, site-resolved contrastive learning extends small-molecule discovery beyond the reach of structure-based modeling (opens in a new tab)
The model paper. Ptarmigan-1 co-embeds protein residues and small molecules without predicting a pose, screening billions of compounds across the human proteome in under a day — and reaching disordered targets where co-folding falls to near-random.
- · Talus Bio
Talus Bio announces collaboration with PRISM BioLab to discover novel modulators of transcription factor and protein-protein interaction targets
A strategic collaboration pairing PRISM's PepMetics® chemistry with Talus's regulome profiling and AI models, against transcription factor and protein-protein interaction targets.
- · Talus Bio
Regulome Summit 2025: a milestone for chromatin biology and drug discovery
The inaugural Regulome Summit brought genome scientists, technologists, and AI researchers to the University of Washington to chart a path toward drugging regulome targets.
- · bioRxiv
Native, Spatiotemporal Profiling of the Global Human Regulome (opens in a new tab)
The platform paper. Compartment-resolved profiling across 36 human cell lines recovers 897 transcription factors — roughly 60% of the annotated human repertoire.
- · Talus Bio
Talus Bio presents preclinical data on transcription factor therapeutic programs at AACR 2025
- · Talus Bio
Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series
- · Talus Bio
Talus Bio announces new VP of Business Development to accelerate pharma partnerships
- · Talus Bio
Introducing Drugging the Undruggable, a new blog series from Talus Bio
- · Substack
Introducing Drugging the Undruggable, a blog series from Talus Bio (opens in a new tab)
The original announcement of the series. Posts now live at /blog.
- · Talus Bio
Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino
- · Talus Bio
Talus Bio announces new Head of Biology to advance transcription factor therapeutics
- · Talus Bio
Life Science Success Podcast Features COO/CFO Michelle Briscoe
- · Fierce Biotech
Talus Bio tacks on $11.2M in additional funding to target hard-to-reach transcription factors (opens in a new tab)
Coverage of the funding round led by Two Bear Capital.
- · Talus Bio
New Funding to Advance Talus Bio’s AI Platform for Therapeutic Discovery
- · Talus Bio
Fierce Biotech Features Talus Bio’s Latest Funding Round
- · Talus Bio
PSBJ Recognizes Talus Bio COO Michelle Briscoe in Voices of Pride Ceremony
- · Talus Bio
New Grants to Accelerate Talus Bio’s Development of Transcription Factor Drugs
- · Talus Bio
The Proteomics Show with Dr. Lindsay Pino
- · Talus Bio
Talus Bio Wants to Knock Proteins off DNA
- · Talus Bio
Talus Announces Close of Seed Funding Round and Hires New COO
- · Talus Bio
Innovating in Oncology Webinar Features Lindsay Pino
- · Talus Bio
Talk is Biotech! Podcast with Guru Singh
- · Talus Bio
The Lady Scientist Podcast Features Lindsay Pino, CTO
- · Talus Bio
Why I Joined A Biotech Startup
Back to Talus Bio